Best High Tech Stocks To Invest In Right Now

tags:APOP,DRNA,EMR,AHPI,HHS,

RealPage Inc (NASDAQ:RP) Chairman Stephen T. Winn sold 794,939 shares of the stock in a transaction dated Friday, June 22nd. The stock was sold at an average price of $56.73, for a total transaction of $45,096,889.47. Following the completion of the transaction, the chairman now directly owns 1,674,645 shares of the company’s stock, valued at $95,002,610.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shares of NASDAQ RP traded down $1.40 on Friday, reaching $54.95. 7,769,150 shares of the company’s stock traded hands, compared to its average volume of 643,512. RealPage Inc has a 12 month low of $35.00 and a 12 month high of $61.95. The company has a market capitalization of $4.95 billion, a price-to-earnings ratio of 152.64 and a beta of 1.13. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.99 and a current ratio of 0.99.

Best High Tech Stocks To Invest In Right Now: Cellect Biotechnology Ltd. (APOP)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on CELLECT BIOTECH/S (APOP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on CELLECT BIOTECH/S (APOP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Lisa Levin] Gainers Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading. Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut. Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading. Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading. Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading. MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading. Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan. Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading. MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading. Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results. Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading. Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings. Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

   

• [By Shane Hupp]

  CELLECT BIOTECH/S (NASDAQ:APOP)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Tuesday. They presently have a $14.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 91.00% from the stock’s previous close.

Best High Tech Stocks To Invest In Right Now: Dicerna Pharmaceuticals, Inc.(DRNA)

Advisors' Opinion:

• [By Max Byerly]

  Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 1,713,672 shares, a growth of 47.9% from the May 31st total of 1,158,865 shares. Based on an average daily trading volume, of 465,952 shares, the days-to-cover ratio is presently 3.7 days. Approximately 4.3% of the shares of the stock are sold short.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Dicerna Pharmaceuticals (DRNA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Dicerna Pharmaceuticals (DRNA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Dicerna Pharmaceuticals (NASDAQ:DRNA) had its price target lifted by equities research analysts at SunTrust Banks to $20.00 in a research report issued to clients and investors on Thursday, The Fly reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. SunTrust Banks’ price target would indicate a potential upside of 37.74% from the stock’s previous close.

Best High Tech Stocks To Invest In Right Now: Emerson Electric Company(EMR)

Advisors' Opinion:

• [By Lee Samaha]

  Indeed, companies like Caterpillar (NYSE:CAT) and Emerson Electric (NYSE:EMR) are seeing increased demand for their capital equipment. Emerson's process-automation orders are growing strongly as its heavy-industry customers are spending again, while Caterpillar's sales in the resource industries segment may well be in the early innings of a multiyear upcycle.

• [By Lee Samaha]

  In common with many other industrial companies, like Danaher, Pentair has been taking action to become a more focused investment proposition for investors. The sale of its valves and controls business to Emerson Electric (NYSE:EMR) in the spring of 2017 turned out to be well-timed for Emerson, as it occurred precisely at the time when oil and gas capital spending started picking up.

• [By Logan Wallace]

  D.A. Davidson & CO. lifted its position in shares of Emerson Electric (NYSE:EMR) by 1.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 574,584 shares of the industrial products company’s stock after buying an additional 7,640 shares during the period. Emerson Electric makes up about 0.8% of D.A. Davidson & CO.’s holdings, making the stock its 25th biggest holding. D.A. Davidson & CO.’s holdings in Emerson Electric were worth $39,244,000 at the end of the most recent reporting period.

• [By Benzinga News Desk]

  Former President George H.W. Bush has been hospitalized in Houston with an infection, just after attending the funeral of his wife, Barbara, a spokesman said Monday: Link

  ECONOMIC DATA Redbook Reports US Retail Sales During First 2 Weeks Of Apr. Up 0.3% MoM, Up 2.8% YoY USA S&P/CaseShiller House Price Index (MoM) for Feb Up 0.7% MoM New home sales report for March will be released at 10:00 a.m. ET. The Conference Board’s consumer sentiment index for April is schedule for release at 10:00 a.m. ET. The Richmond Fed manufacturing index for April will be released at 10:00 a.m. ET. The Treasury is set to auction 4-and 52-week bills at 11:30 a.m. ET. The Treasury will auction 2-year notes at 1:00 p.m. ET. ANALYST RATINGS Leerink upgraded Cardinal Health (NYSE: CAH) from Market Perform to Outperform Berenberg upgraded Emerson Electric (NYSE: EMR) from Sell to Hold Mizuho downgraded Skyworks (NASDAQ: SWKS) from Buy to Neutral BMO downgraded Texas Roadhouse (NASDAQ: TXRH) from Outperform to Market Perform

  This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

• [By Stephan Byrd]

  Wilkins Investment Counsel Inc. cut its stake in shares of Emerson Electric (NYSE:EMR) by 1.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 111,625 shares of the industrial products company’s stock after selling 2,015 shares during the quarter. Emerson Electric makes up approximately 2.4% of Wilkins Investment Counsel Inc.’s portfolio, making the stock its 17th biggest position. Wilkins Investment Counsel Inc.’s holdings in Emerson Electric were worth $7,624,000 at the end of the most recent reporting period.

Best High Tech Stocks To Invest In Right Now: Allied Healthcare Products Inc.(AHPI)

Advisors' Opinion:

• [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million. Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results. Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. 21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33. Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27. Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating. PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat. NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399. Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643. Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16. Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results. GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results. The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results. Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Best High Tech Stocks To Invest In Right Now: Harte-Hanks, Inc.(HHS)

Advisors' Opinion:

• [By Logan Wallace]

  Noble Financial reissued their buy rating on shares of Harte Hanks (NYSE:HHS) in a report issued on Thursday.

  HHS has been the topic of a number of other research reports. ValuEngine upgraded shares of Harte Hanks from a strong sell rating to a sell rating in a report on Tuesday, August 28th. Zacks Investment Research cut shares of Harte Hanks from a hold rating to a strong sell rating in a report on Tuesday, August 14th.

• [By Logan Wallace]

  These are some of the news stories that may have effected Accern’s rankings:

  Get Harte Hanks alerts: Harte-Hanks (HHS) Name Four New Independent Directors (streetinsider.com) Harte Hanks (HHS) Given $15.00 Consensus Price Target by Brokerages (americanbankingnews.com) Harte Hanks to Appoint Four New Independent Directors to the Board (feeds.benzinga.com) Harte Hanks (HHS) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com) Harte Hanks (HHS) Shares March Higher, Can It Continue? (zacks.com)

  Shares of Harte Hanks traded up $0.65, reaching $10.96, during trading hours on Friday, according to Marketbeat.com. The stock had a trading volume of 46,930 shares, compared to its average volume of 18,474. Harte Hanks has a 12 month low of $7.30 and a 12 month high of $14.40. The stock has a market capitalization of $64.54 million, a price-to-earnings ratio of -9.13 and a beta of 0.90.

• [By Ethan Ryder]

  ValuEngine upgraded shares of Harte Hanks (NYSE:HHS) from a sell rating to a hold rating in a research report sent to investors on Monday.

  HHS has been the topic of a number of other reports. Noble Financial reaffirmed a buy rating on shares of Harte Hanks in a research note on Monday, March 5th. Zacks Investment Research raised shares of Harte Hanks from a hold rating to a strong-buy rating and set a $12.00 target price on the stock in a research note on Tuesday, May 15th.

• [By Lisa Levin] Gainers Bioblast Pharma Ltd. (NASDAQ: ORPN) shares rose 29.6 percent to $3.22. Mannatech, Incorporated (NASDAQ: MTEX) surged 23.3 percent to $19.60 after the company reported commencement of modified Dutch auction cash tender for up to $16 million of common stock. Evolus, Inc. (NASDAQ: EOLS) shares rose 22.1 percent to $15.8003. Quotient Limited (NASDAQ: QTNT) gained 18.1 percent to $5.54 following commencement of EU blood grouping field trial. Shineco, Inc. (NASDAQ: TYHT) climbed 17.1 percent to $1.9899 following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million. CPI Card Group Inc. (NASDAQ: PMTS) rose 17 percent to $3.0999. Dover Downs Gaming & Entertainment, Inc. (NYSE: DDE) shares climbed 12 percent to $2.2613. The stock spiked more than 14 percent Thursday near the close as traders circulate word the Delaware lottery is planning to introduce full sports betting in June. Harte Hanks, Inc. (NYSE: HHS) shares gained 7.2 percent to $11.05 after the company late Thursday appointed four new independent directors to board. Cronos Group Inc. (NASDAQ: CRON) rose 6.4 percent to $6.17. VivoPower International PLC (NASDAQ: VVPR) shares gained 6.3 percent to $3.74. Global Self Storage, Inc. (NASDAQ: SELF) shares climbed 6 percent to $4.20.

  Check out these big penny stock gainers and losers